Back to results
US 7,741,056 B2Granted
Use of A33 antigens and JAM-IT
AssigneeGenentech, Inc.
InventorsAvi Ashkenazi, Sherman Fong, Audrey Goddard, Austin L. Gurney, Mary A. Napier, Daniel Tumas, Menno Van Lookeren, William I. Wood
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods of treating and diagnosing disorders characterized the by the presence of antigens associated with inflammatory diseases and/or cancer.
Claims4
A polypeptide comprising amino acids 21 to 276 of SEQ ID NO:
- 32.
An immunoadhesin comprising amino acids 21 to 276 of SEQ ID NO:
- 32, fused to an immunoglobulin constant region sequence.
Dependencies are inferred from the claim text.